Deoxyshikonin
Product Specifications
CAS Number
43043-74-9
Target
HIF/HIF Prolyl-Hydroxylase|||Apoptosis|||PI3K|||Antibacterial
Related Pathways
PI3K/Akt/mTOR signaling|||Chromatin/Epigenetic|||Microbiology/Virology|||Metabolism|||Apoptosis
Purity
0.9958
Bioactivity
1. Deoxyshikonin (Arnebin 7) may be a new drug candidate for wound healing and treatment of lymphatic diseases. 2. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formation. 3. Deoxyshikonin and dodecyl gallate show significantly synergic antimicrobial activity with penicillin in vivo and in vitro, and can effectively reduce nasopharyngeal and lung colonization caused by different penicillin-resistant pneumococcal serotypes.
Smiles
CC(C)=CCCC1=CC(=O)c2c(O)ccc(O)c2C1=O
Molecular Formula
C16H16O4
Molecular Weight
272.3
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
211523-01 50 µL
INTS9 (Integrator Complex Subunit 9, INT9, RC74, CPSF2L) discontinued
Ask
View Details